CT Coronary Artery Calcium Scoring Appropriateness Algorithm and Patient Management Recommendations

CACS Patient Management Recommendations - PDF Download

Appropriateness Algorithm

Appropriateness Algorithm

Patient Management Recommendations

FOR PATIENTS WITH CACS OF 0:
1. LDL-C goal greater than 130 mg/dL.
2. If triglycerides 200 – 499 mg/dL: non-HDL goal [total – (HDL-C) greater than 160 mg/dL].
3. Therapeutic lifestyle change (TLC) therapy for six to 12 months; consider statins as first-line drugs for those with persistent LDL-C ?160 mg/dL after six to 12 months.

FOR ALL PATIENTS WITH ANY DETECTABLE CORONARY CALCIUM:
1. Diet, regular cardiovascular exercise, weight reduction to body mass index <25.
2. Complete smoking cessation.
3. Blood pressure <140/90 mm Hg; for type 2 DM: ?130/80.

FOR PATIENTS WITH CACS 1 – 99:
1. LDL-C goal greater than 130 mg/dL; optional greater than 100.
2. If triglycerides 200 – 499 mg/dL: non-HDL-C goal greater than 160 mg/dL; optional greater than 130.
3. TLC therapy for six months; statins first-line drugs for those with persistent LDL-C ?130 mg/dL after six months.
4. For persistent elevation in non-HDL-C consider high-intensity statin; or add fibrate, Niacin ER or ezetimibe.
5. Consider ASA 81 mg daily in males.

FOR PATIENTS WITH CACS 100 – 399:
1. LDL-C goal greater than 100 mg/dL; optional greater than 70.
2. If triglycerides 200 – 499 mg/dL: non-HDL-C goal greaster than 130 mg/dL; optional greater than 100.
3. TLC therapy for three months; consider statins as first-line drugs for those with LDL-C >100 mg/dL after three months.
4. For persistent elevation in non-HDL-C consider high-intensity statin; or add fibrate, Niacin ER or ezetimibe.
5. Aspirin 81 mg daily.
6. Consider referring to cardiology (216-844-3800) for overview of risk factor management strategy and to explore research options.

FOR PATIENTS WITH CACS > 400:
1. LDL-C goal greater than 70 mg/dL.
2. If triglycerides 200 – 499 mg/dL: non-HDL-C goal greater than 100 mg/dL. 
3. Begin TLC therapy and usually higher dose statin therapy concomitantly.
4. For persistent elevation in non-HDL-C consider high-intensity statin; or add fibrate, Niacin ER or ezetimibe.
5. Combination therapy often necessary.
6. Aspirin 81 mg daily.
7. Stress echocardiography advised.
 - No ischemia detected: continue aggressive CHD risk factor management.
 - Ischemia detected, not strongly positive: anti-ischemic medical therapy plus aggressive risk factor management.
 - Profound ischemia detected (?2.5 mm ST depression; ST elevation; ?20 mm Hg in systolic BP at peak exercise, severely impaired exercise capacity (greater than 3 minutes on a standard Bruce protocol in absence of orthopedic limitations): recommend cardiology consultation.

8. Consider referring to cardiology (216-844-3800) for overview of risk factor management strategy and to explore research options.